oseltamivir has been researched along with 2019 Novel Coronavirus Disease in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 62 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abbew, AW; Chen, Z; Ge, S; Gu, J; Qiu, S; Wu, Z; Xu, S; Zeeshan, QM | 1 |
Iacobucci, G | 1 |
Haesendonckx, S; Leopold, L; Van Dromme, I; van Duijnhoven, W; Witek, J | 1 |
Balan, V; Blumberg, L; Cai, E; Cheng, V; Dagens, A; Dahmash, D; Groves, H; Harriss, E; Hart, P; Horby, PW; Jacob, S; Joseph, R; Lipworth, S; Michelen, M; Oti, A; Rigby, I; Sigfrid, L | 1 |
Aires, L; Alisson-Silva, F; Amaral, FC; Antônia, J; Báfica, A; Barroso, SPC; Burgel, PR; Chollet-Martin, S; Costa, VV; Cunha, FQ; de Oliveira Formiga, R; de Souza, FRO; Faria, LF; Fonseca, FR; Heck, N; Hurtado-Nedelec, MM; Lorenzini, CB; Macauley, MS; Mansur, DS; Martin, C; Maurici, R; Mendes, DAGB; Morrot, A; Natale, CC; Paula, NM; Queiroz-Junior, CM; Rocha, EL; Santos, AA; Santos, FRS; Silva, PCS; Sordi, R; Souza, CF; Spiller, F; Starick, MR; Van Weyenbergh, J; Wanderley, CWS; Witko-Sarsat, V | 1 |
Chan, KKP; Hui, DSC | 1 |
Abdel-Moneim, AS; Al Yami, MR; Alghamdi, AN; Alghamdi, RK; Alharthi, AA; Almakki, RA; Alnemari, AA; Alsalmi, NM; Alwagdani, AA; Kadry, DY; Mahfouz, MEM; Osman, AS | 1 |
Al Rumaih, Z; Chaudhri, G; Karupiah, G; Kc, R; Kels, MJT; Malley, R; Ng, E; Pandey, P | 1 |
Bartelt-Hunt, SL; Chen, C; Xu, X; Zhang, Y; Zhu, R; Zou, H | 1 |
Miyairi, I; Okubo, Y; Uda, K | 1 |
Arabi, YM; Fowler, R; Hayden, FG | 1 |
Lu, X; Pan, B; Sun, P; Sun, W; Xu, C | 1 |
Duan, Y; Zhou, C; Zhu, HL | 1 |
Ding, D; Yao, W; Zhu, C | 1 |
Dai, J; Duan, J; Fu, Z; Lin, J; Tan, T | 1 |
Kutlu, Ö; Metin, A | 1 |
Rezaei, N; Yousefzadegan, S | 1 |
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM | 1 |
Akyollu, B; Arpali, E; Kocak, B; Tekin, S; Turkmen, A; Yelken, B | 1 |
Albuquerque, BC; Alexandre, MAA; Baía-da-Silva, D; Balieiro, AAS; Bassat, Q; Borba, MGS; Brito, M; Brito-Sousa, JD; Croda, J; Daniel-Ribeiro, CT; Fontes, CJ; Guerra, MVF; Hajjar, LA; Lacerda, MVG; Melo, GC; Monteiro, WM; Mourão, MPG; Naveca, FG; Nogueira, ML; Pacheco, AGF; Pinto, RC; Romero, GAS; Sampaio, VS; Santos, JDO; Schwarzbold, A; Siqueira, AM; Val, FFA; Xavier, MS | 1 |
Bekci, T | 1 |
Daneshpazhooh, M; Isazade, A; Noormohammadpour, P; Soori, T | 1 |
Song, S; Wang, X; Xiong, Y; Ye, G | 1 |
Lu, G; Wang, J | 1 |
Ledford, H | 1 |
Aydın, GÇ; Azap, A; Dursun, B; Öztürk, HH; Ürün, Y; Utkan, G; Yazgan, SC; Yekedüz, E | 1 |
Berk, A; Duman, H; Kaya, F; Mutlu, H; Ozaras, R; Ucar, DH | 1 |
He, J; Huang, D; Li, J; Liang, W; Liu, L; Xia, Z; Xu, X; Zhao, Y | 1 |
Fujishima, S | 1 |
Du, Z; Galvani, AP; Krug, RM; Meyers, LA; Nugent, C | 1 |
Çapar, G; Köse, M; Medetalibeyoğlu, A; Şenkal, N; Tükek, T | 1 |
Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N | 1 |
Bongard, E; Butler, CC; Cianci, D; Coenen, S; de Paor, M; Gobat, N; Goossens, H; Ieven, M; Saville, BR; van der Velden, AW; Verheij, TJ | 1 |
Amenta, F; Nittari, G; Pallotta, G; Tayebati, SK | 1 |
Firouzabadi, FD; Firouzabadi, MD; Ghalehbaghi, B; Goudarzi, S; Jahandideh, H; Roomiani, M | 1 |
Arish, M; Naz, F | 1 |
Cai, W; Cao, Y; Chen, X; Hu, F; Li, F; Li, L; Li, Y; Lin, W; Ou, X; Tang, X; Wen, C; Xie, Z | 1 |
Altunok, ES; Cengel, F; Ekin, EE; Gurkan, O; Yilmaz, A | 1 |
Chen, C; Chen, Y; Hu, F; Liu, J; Song, J; Song, Y; Tang, X; Ye, M; Yin, G; Zhang, Y | 1 |
Chen, Y; Ding, M; Jiang, X; Lan, K; Lavillete, D; Li, H; Li, S; Liu, Y; Shan, J; Shang, W; Shen, Z; Sun, Y; Tong, Y; Wang, R; Wang, Y; Wu, Y; Xiao, G; Xiong, R; Xu, K; Xu, L; Zhang, L; Zhao, Y; Zhao, Z; Zhu, L; Zou, G | 1 |
Jiang, H; Xu, Y | 1 |
Akram, J; Azhar, S; Khan, KS; Latif, W; Shahzad, M | 1 |
Abd El Ghafar, MS; Abd-Elsalam, S; Abdo, EF; Ahmed, OA; Alboraie, M; Esmail, ES; Khalaf, M; Medhat, MA; Serangawy, GN; Soliman, S | 1 |
Esam, Z | 1 |
Mamishi, S; Navaeian, A; Shabanian, R | 1 |
Akat, H; Laloglu, F; Orbak, Z | 1 |
Ahmadinejad, Z; Assari, R; Ayoobi Yazdi, N; Javanshayani, P; Khalili Afousi, H; Mazloomi, SH; Ziaee, V | 1 |
Chiba, S | 1 |
Bakheet, N; El-Shazly, M; Fouad, R; Hussin, W; Kassem, AM | 1 |
Gao, Q; Liu, D; Ma, D; Song, C; Tan, J; Xu, C; Yuan, Y | 1 |
Wen, S; Xu, X; Yadav, AK; Yu, L | 1 |
Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M | 1 |
Arouche, TDS; Costa, FLP; Filho, TSA; Júnior, RNC; Martins, AY; Neto, AMJC; Ramalho, TC | 1 |
Aalipour, MA; Darazam, IA; Ghorbani, F; Pakdaman, H; Ramezani, M; Sagharichi, M; Simani, L | 1 |
Baeza-Flores, GDC; Denis-García, CA; Flores-Barrientos, OI; Gonzalez-Castro, TB; Guzmán-Priego, CG; Juárez-Rojop, IE; López-Brito, CR; Narváez-Osorio, V; Nolasco-Rosales, GA; Pérez-García, A; Ruíz-Quiñonez, JA; Tovilla-Zarate, CA | 1 |
Milano, G | 1 |
Akbulut Koyuncu, İM; Kızıltunç, E; Uğurlu Ilgın, B | 1 |
Dabbous, HM; Ebeid, FFS; El Assal, G; El-Sayed, MH; Elgaafary, M; Elghazaly, H; Fawzy, E; Hassany, SM; Riad, AR; Sherief, AF; TagelDin, MA | 1 |
Isnaini, S; Ramatillah, DL | 1 |
Anedda, L; Bianchini, L; Cuzzolin, L; Fanos, V; Finco, G; Marcialis, MA | 1 |
Cahyadi, A; Henrina, J; Pusparani, A | 1 |
Berk, H; Demir Önder, K; Öztoprak, N; Seremet Keskin, A; Seyman, D | 1 |
9 review(s) available for oseltamivir and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines.
Topics: Aged; Antiviral Agents; Child; Child, Preschool; COVID-19; Female; Humans; Influenza, Human; Oseltamivir; Pandemics; Pregnancy | 2022 |
Antiviral therapies for influenza.
Topics: Antiviral Agents; COVID-19; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Zanamivir | 2023 |
Critical care management of adults with community-acquired severe respiratory viral infection.
Topics: Adult; Antiviral Agents; Community-Acquired Infections; Coronavirus Infections; COVID-19; Critical Care; Critical Illness; Evidence-Based Medicine; Humans; Influenza, Human; Intensive Care Units; Macrolides; Noninvasive Ventilation; Oseltamivir; Pneumonia; Pneumonia, Viral; Respiration, Artificial; Severe Acute Respiratory Syndrome; Severity of Illness Index | 2020 |
Understanding of COVID-19 based on current evidence.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Animals; Antiviral Agents; Betacoronavirus; China; Chiroptera; Communicable Disease Control; Coronavirus Infections; COVID-19; Disease Management; Humans; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Survival Analysis | 2020 |
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment | 2020 |
Current pharmacological treatments for SARS-COV-2: A narrative review.
Topics: Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Immunity, Innate; Inflammation Mediators; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles | 2021 |
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Female; Fever; Humans; Hydroxychloroquine; Levetiracetam; Male; Middle Aged; Myalgia; Opsoclonus-Myoclonus Syndrome; Oseltamivir; SARS-CoV-2; Valproic Acid | 2021 |
What if COVID-19 affects the child: which weapons and how to use them.
Topics: Adenosine Monophosphate; Adolescent; Age Factors; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Carrier State; Child; Child, Preschool; Chloroquine; Continuous Renal Replacement Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Oseltamivir; Receptors, Cell Surface; Respiration, Artificial; Ribavirin; Ritonavir; SARS-CoV-2; Severity of Illness Index; Thrombosis | 2021 |
6 trial(s) available for oseltamivir and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
The Hospital Recovery Scale: A clinically useful endpoint in patients hospitalized with influenza.
Topics: Antiviral Agents; COVID-19; Hospitalization; Hospitals; Humans; Influenza, Human; Oseltamivir; Treatment Outcome | 2022 |
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Brazil; Chloroquine; Coronavirus Infections; COVID-19; Disease Outbreaks; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tertiary Care Centers | 2020 |
Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Europe; Female; Fever; Headache; Humans; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Time Factors; Treatment Outcome; Young Adult | 2020 |
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A struc
Topics: Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Research Design; SARS-CoV-2 | 2020 |
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Egypt; Female; Humans; Hydrocortisone; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome | 2020 |
Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
Topics: Adult; Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Humans; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pyrazines; Treatment Outcome | 2021 |
47 other study(ies) available for oseltamivir and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Unravelling multiple removal pathways of oseltamivir in wastewater by microalgae through experimentation and computation.
Topics: Biomass; Chlorella; COVID-19; Humans; Microalgae; Oseltamivir; SARS-CoV-2; Wastewater | 2022 |
Covid-19: Stockpiling antivirals risks repeating Tamiflu mistakes, experts warn.
Topics: Antiviral Agents; COVID-19; Dermatologic Agents; Humans; Influenza, Human; Oseltamivir | 2022 |
Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19.
Topics: Animals; COVID-19; Humans; Lipopolysaccharides; Matrix Metalloproteinase 9; Mice; Neuraminidase; Neutrophils; Oseltamivir; Reactive Oxygen Species; Sepsis; Zanamivir | 2023 |
Comparison of Different Antiviral Regimens in the Treatment of Patients with Severe COVID-19: A Retrospective Cohort.
Topics: Antiviral Agents; COVID-19; Humans; Imipenem; Linezolid; Oseltamivir; Retrospective Studies; SARS-CoV-2 | 2023 |
Therapeutic Targeting of Inflammation and Virus Simultaneously Ameliorates Influenza Pneumonia and Protects from Morbidity and Mortality.
Topics: Animals; Antiviral Agents; COVID-19; Cytokines; Etanercept; Humans; Inflammation; Influenza A virus; Influenza, Human; Mice; Morbidity; Oseltamivir; Pneumonia; SARS-CoV-2 | 2023 |
COVID-19 related antiviral drugs are less adsorbable on sediment under alkaline and high cation conditions.
Topics: Adsorption; Antiviral Agents; COVID-19; Geologic Sediments; Humans; Oseltamivir; Pandemics; Ritonavir | 2023 |
Trends in Influenza and Related Health Resource Use During 2005-2021 Among Children in Japan.
Topics: Antiviral Agents; Child; COVID-19; Health Resources; Humans; Influenza, Human; Japan; Oseltamivir; Pandemics; Retrospective Studies | 2023 |
Advance of promising targets and agents against COVID-19 in China.
Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins | 2020 |
A Cured Patient With 2019-nCoV Pneumonia.
Topics: Aged; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Female; Humans; Moxifloxacin; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing, China.
Topics: Adult; Betacoronavirus; Child; China; Coronavirus Infections; COVID-19; Disease Transmission, Infectious; Family Health; Humans; Infection Control; Interferon-alpha; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?
Topics: Aged; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Psoriasis | 2020 |
Case Report: Death due to COVID-19 in Three Brothers.
Topics: Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Fatal Outcome; Genetic Predisposition to Disease; Humans; Hydroxychloroquine; Iran; Lung; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Siblings; Tomography, X-Ray Computed | 2020 |
Case report: A kidney transplant patient with mild COVID-19.
Topics: Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Disease Management; Female; Fever; Glucocorticoids; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisone; SARS-CoV-2; Severity of Illness Index; Tacrolimus | 2020 |
"Reversed halo sign" on 3D CT in COVID-19.
Topics: Adult; Antimalarials; Antiviral Agents; Betacoronavirus; Body Fluids; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Imaging, Three-Dimensional; Male; Nasopharynx; Oseltamivir; Pandemics; Pneumonia; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deprescriptions; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Immunoglobulins, Intravenous; Immunologic Factors; Iran; Lopinavir; Male; Mycophenolic Acid; Oseltamivir; Pandemics; Pemphigoid, Benign Mucous Membrane; Pneumonia, Viral; Prednisolone; Ritonavir; Rituximab; SARS-CoV-2; Tomography, Spiral Computed | 2020 |
Family cluster of three recovered cases of pneumonia due to severe acute respiratory syndrome coronavirus 2 infection.
Topics: Adult; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Family Health; Female; Genome, Viral; Humans; Male; Methylprednisolone; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Dynamic changes in routine blood parameters of a severe COVID-19 case.
Topics: Anti-Bacterial Agents; Betacoronavirus; Biomarkers; Blood Platelets; C-Reactive Protein; Cell Count; Convalescence; Coronavirus Infections; COVID-19; Erythrocytes; Female; Humans; Middle Aged; Monocytes; Neutrophils; Oseltamivir; Pandemics; Pneumonia, Viral; Prognosis; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index | 2020 |
Dozens of coronavirus drugs are in development - what happens next?
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Coronavirus Infections; COVID-19; Drug Development; Drug Industry; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral | 2020 |
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
Topics: Aged; Antineoplastic Agents, Immunological; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Lung Neoplasms; Melanoma; Multiple Chronic Conditions; Nivolumab; Oseltamivir; Pandemics; Pneumonia, Viral; Programmed Cell Death 1 Receptor; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Covid-19 and exacerbation of psoriasis.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Psoriasis; SARS-CoV-2 | 2020 |
SARS-CoV-2 persisted in lung tissue despite disappearance in other clinical samples.
Topics: Aged; Antiviral Agents; Betacoronavirus; Blood Loss, Surgical; Blood Volume; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Extracorporeal Membrane Oxygenation; Fatal Outcome; Humans; Hypertension; Lung; Lung Transplantation; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Virus Shedding | 2020 |
COVID-19: Stay Cool toward Corticosteroids.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Humans; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Modeling mitigation of influenza epidemics by baloxavir.
Topics: Antiviral Agents; Betacoronavirus; Cell Proliferation; Coronavirus Infections; COVID-19; Dibenzothiepins; Epidemics; Humans; Influenza, Human; Morpholines; Orthomyxoviridae; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Public Health; Pyridines; Pyridones; RNA, Messenger; SARS-CoV-2; Seasons; Thiepins; Triazines; Viral Load; Virus Replication | 2020 |
Characteristics of the initial patients hospitalized for COVID-19: a single-center report
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Female; Fever; Health Personnel; Humans; Hydroxychloroquine; Hypertension; Intensive Care Units; Lung; Male; Middle Aged; Myalgia; Oseltamivir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Travel; Turkey; Young Adult | 2020 |
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin | 2020 |
Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coronavirus Infections; Cough; COVID-19; Diarrhea; Dyspnea; Female; Fever; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Symptom Assessment; Young Adult | 2020 |
Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?
Topics: Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Humans; Indans; Influenza A Virus, H1N1 Subtype; Lysophospholipids; Mice; Orthomyxoviridae Infections; Oseltamivir; Oxadiazoles; Pandemics; Pneumonia, Viral; SARS-CoV-2; Sphingosine; Sphingosine-1-Phosphate Receptors | 2020 |
Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019.
Topics: Adult; Anal Canal; Antiviral Agents; C-Reactive Protein; Chloroquine; COVID-19; COVID-19 Testing; Female; Hospitalization; Humans; Indoles; Intensive Care Units; Lymphopenia; Male; Middle Aged; Oseltamivir; Pharynx; Retrospective Studies; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Viral Load | 2021 |
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Enoxaparin; Female; Fever; Humans; Hydroxychloroquine; Lung; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Pneumothorax; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2020 |
Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Female; Hospitalization; Humans; Immunoglobulins; Indoles; Interferons; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Retrospective Studies; Risk Factors; SARS-CoV-2; Time Factors; Virus Shedding | 2020 |
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Topics: Animals; Antiviral Agents; Betacoronavirus; Binding Sites; Cell Line; Coronavirus Infections; COVID-19; Crotonates; Cytokine Release Syndrome; Dihydroorotate Dehydrogenase; Drug Evaluation, Preclinical; Gene Knockout Techniques; Humans; Hydroxybutyrates; Influenza A virus; Leflunomide; Mice; Mice, Inbred BALB C; Nitriles; Orthomyxoviridae Infections; Oseltamivir; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pandemics; Pneumonia, Viral; Protein Binding; Pyrimidines; RNA Viruses; SARS-CoV-2; Structure-Activity Relationship; Thiazoles; Toluidines; Ubiquinone; Virus Replication | 2020 |
Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase.
Topics: Animals; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dihydroorotate Dehydrogenase; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Mice; Molecular Structure; Orthomyxoviridae Infections; Oseltamivir; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pandemics; Pneumonia, Viral; Pyrimidines; SARS-CoV-2 | 2020 |
Protective potential of expectorants against COVID-19.
Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dioxolanes; Expectorants; Humans; Medicine, Chinese Traditional; Mucus; Oseltamivir; Pandemics; Pneumonia, Viral; Povidone; SARS-CoV-2 | 2020 |
Acute aortic dissection in a patient with Williams syndrome infected by COVID-19.
Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Aortic Aneurysm; Aortic Dissection; Aortic Stenosis, Supravalvular; Aortitis; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Fatal Outcome; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Male; Methylprednisolone; Oseltamivir; Recurrence; Ritonavir; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Williams Syndrome | 2021 |
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed | 2021 |
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
Topics: Adalimumab; Adult; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Betacoronavirus; Biological Therapy; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Combinations; Drug Therapy, Combination; Humans; Lopinavir; Male; Methotrexate; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisolone; Ritonavir; SARS-CoV-2 | 2020 |
Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19.
Topics: Adult; Antiviral Agents; China; COVID-19; Female; Humans; Hypoxia; Influenza, Human; Male; Middle Aged; Oseltamivir; Outpatients; SARS-CoV-2 | 2021 |
Persistent hiccup: A rare presentation of COVID-19.
Topics: Baclofen; Biomarkers; COVID-19; COVID-19 Testing; Fever; Hiccup; Humans; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pharyngitis; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2021 |
A retrospective comparison of drugs against COVID-19.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Immunoglobulin M; Indoles; Length of Stay; Lopinavir; Male; Middle Aged; Oseltamivir; Retrospective Studies; Ritonavir; SARS-CoV-2; Young Adult | 2021 |
Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
Topics: Azithromycin; Coronavirus 3C Proteases; COVID-19; Heparin; Humans; Ivermectin; Lopinavir; Molecular Docking Simulation; Oseltamivir; Ritonavir; SARS-CoV-2 | 2021 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations; Dyspnea; Fatigue Syndrome, Chronic; Female; Fever; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Oseltamivir; Research Design; Ritonavir; SARS-CoV-2; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Survivors | 2021 |
Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 1; Female; Hospital Mortality; Hospitals; Humans; Hydroxychloroquine; Length of Stay; Male; Mexico; Middle Aged; Obesity; Oseltamivir; Retrospective Studies; SARS-CoV-2; Sex Factors | 2021 |
[Scientific research in times of pandemics.]
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Vaccines; Disease Outbreaks; Drug Approval; European Union; Humans; Influenza, Human; Information Dissemination; Informed Consent; Oseltamivir; Pandemics; Peer Review, Research; Periodicals as Topic; Politics; Publishing; Research; Risk; SARS-CoV-2; Time Factors; United States | 2021 |
Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxychloroquine; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Oseltamivir; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Young Adult | 2021 |
Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Comorbidity; COVID-19; Female; Hospitals, Private; Humans; Hydroxychloroquine; Indonesia; Kaplan-Meier Estimate; Male; Middle Aged; Oseltamivir; Pandemics; Prospective Studies; SARS-CoV-2; Treatment Outcome | 2021 |
Co-infection of COVID-19 and recurrent malaria.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Coinfection; COVID-19; COVID-19 Drug Treatment; Humans; Indonesia; Malaria; Male; Oseltamivir; Recurrence; SARS-CoV-2; Young Adult | 2021 |
Retrospective evaluation of seven different treatment protocols in hospitalized COVID-19 patients
Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Amides; Antiviral Agents; Clinical Protocols; COVID-19; COVID-19 Nucleic Acid Testing; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pyrazines; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult | 2021 |